NICE updates guidance on fever in young children

NICE updates guidance on fever in young children

August 14 2017 A number of changes have been made to the NICE guidelines and assessing and...

National measles guidelines published

National measles guidelines published

August 14 2017 Updated guidelines relating to measles identification, case management and control...

Wales recommits to supporting those affected by neurological conditions

Wales recommits to supporting those affected by neurological conditions

August 1 2017The Welsh Government has renewed its commitment to supporting people with...

Study indicates 11.8m people should be on statins

Study indicates 11.8m people should be on statins

August 3 2017 Millions of people are not being prescribed a statin despite NICE guidelines...

EMA warns against use of riociguat in PH-IIP type pulmonary hypertension

EMA warns against use of riociguat in PH-IIP type pulmonary hypertension

June 29 2016 Adempas (riociguat) should not be used in patients with symptomatic pulmonary...

  • NICE updates guidance on fever in young children

    NICE updates guidance on fever in young children

    Monday, 14 August 2017 09:59
  • National measles guidelines published

    National measles guidelines published

    Monday, 14 August 2017 09:16
  • Wales recommits to supporting those affected by neurological conditions

    Wales recommits to supporting those affected by neurological conditions

    Saturday, 05 August 2017 13:54
  • Study indicates 11.8m people should be on statins

    Study indicates 11.8m people should be on statins

    Saturday, 05 August 2017 14:51
  • EMA warns against use of riociguat in PH-IIP type pulmonary hypertension

    EMA warns against use of riociguat in PH-IIP type pulmonary hypertension

    Wednesday, 29 June 2016 10:44

vaccinationJune 27 2016

The 2015-16 influenza vaccine effectiveness has been calculated at 57.6% in children and young people aged 2 to 17 years. However, the vaccine effectiveness was 29.1% for adults aged over 65 years.

In its provisional end-of season results for the 2015-16 flu season, Public Health England said that overall influenza vaccine effectiveness was 52.4%, consistent with previous estimates. Vaccine effectiveness among younger adults (18-44 years) was 55.3%, and for those aged 45-64 years was 55.4%.

Children and young people had been given the vaccine by nasal spray (CNSV). PHE noted that “similar evidence of CNSV effectiveness has been reported in Finland, in contrast to the USA where it has been reported that CNSV has been less effective.”

PHE’s latest HPR newsletter points out that in the 2014-15 season when CSNV was piloted among primary school-aged children, “there was not only a 94% reduction in GP influenza-like illness consultation rates in the children themselves (and a 74% reduction in A&E respiratory attendances and a 93% reduction in hospital admissions among children) but also, in the same pilot areas, a 59% reduction in GP consultation rates for ILI in adults, compared to non-pilot areas.”

PHE will publish a fuller report on seasonal flu vaccine effectiveness later in 2016.

Links:

PHE Research and analysis HPR vol 10 issue 20 June 24

PHE Influenza vaccine effectiveness: 2015 to 2016 estimates

PHE provisional data summary

Clinical News

August 18 2017 GPs lack familiarity with current physical activity guidelines, a survey has found. Only 20% of the 1,013 GPs in England responding to the survey “were broadly or very familiar with the...
December 10 2015 A doctor may find themselves the subject of an investigation at any time in their career, from medical students to trainee doctors, GPs or consultants. Whether it’s an issue...